Global Soft Tissue Sarcoma Market Report 2024

Soft Tissue Sarcoma Global Market Report 2024 – By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, Other Treatments), By Route of Administration (Oral, Parenteral, Other Route of Administrations), By End-Users (Hospitals, Homecare, Specialty Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Soft Tissue Sarcoma Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Soft Tissue Sarcoma Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Soft Tissue Sarcoma Market Definition And Segments

Soft tissue sarcoma refers to a disease where cancer cells form in the soft tissues of the body which can be diagnosed through biopsy techniques. It is commonly caused in tissues including blood arteries, muscle, neurons, and fat.

The main treatment types of soft tissue sarcoma are targeted therapy, chemotherapy, anti-angiogenesis drugs, radiation therapy, and others. Targeted therapy refers to treatment that specifically targets the genes, proteins, or tissue environment that supports the growth and survival of cancer and prevents cancer cells from proliferating, dividing, and creating new cells. The various routes of administration include oral, parenteral, and others. These are used by various end-users such as hospitals, homecare, specialty centers, and others.

The soft tissue sarcoma market covered in this report is segmented –

1) By Treatment: Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, Other Treatments

2) By Route of Administration: Oral, Parenteral, Other Routes of Administration

3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users

The soft tissue sarcoma market size has grown strongly in recent years. It will grow from $2.87 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to limited treatment options, evolving understanding of sarcoma biology, growth in cancer research funding, rising prevalence of soft tissue sarcoma, and expansion of healthcare infrastructure.

The soft tissue sarcoma market size is expected to see strong growth in the next few years. It will grow to $4.3 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to development of targeted therapies for soft tissue sarcoma, increasing focus on personalized medicine, expansion of clinical trials for sarcoma treatments, growing awareness and early detection initiatives, Major trends in the forecast period include integration of immunotherapy in soft tissue sarcoma treatment, development of combination therapies, emphasis on patient-centric care models, rise in the use of liquid biopsies, advances in sarcoma genomics.

Surge In Cancer Incidence Driving Soft Tissue Sarcoma Market Growth

The surge in cancer incidence is expected to propel the growth of the soft tissue sarcoma market going forward. Cancer is a broad category of illnesses that can develop in any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. The rise in cancer incidence increases the need for diagnostic procedures, therapeutic regimens, and supportive care choices to meet the unique requirements of patients with several types of cancer or sarcoma, which boosts the market for soft tissue sarcomas. For instance, in 2021, According to the American Cancer Society, 1.8 million new cancer cases were diagnosed in 2020. Furthermore, according to September 2020 data published by the National Cancer Institute, a US-based government agency part of the National Institutes of Health, 1,806,590 new cancer cases were recorded, indicating that 43% of all cancers diagnosed in men in the United States in 2020, up from 1,752,735 in the previous year, i.e., 2019. Therefore, the surge in cancer incidence is driving the growth of the soft tissue sarcoma market.

Increasing Healthcare Expenditure Fuels Growth Of Soft Tissue Sarcoma Market

The increasing healthcare expenditure is expected to propel the growth of the soft tissue sarcoma market. Healthcare refers to the organized provision of medical services, treatments, preventive care, and management of health-related issues for individuals or communities. Higher healthcare expenditures can result in increased funding for medical research, including cancer research. This can lead to advancements in understanding soft tissue sarcoma, discovering new treatment modalities, and improving overall patient outcomes. For instance, in the Economic Survey of 2022, an annual document of the Ministry of Finance, Government of India, India’s public expenditure on healthcare stood at 2.1% of GDP in 2021–22. Moreover, according to a survey of global medical insurers conducted by Willis Towers Watson Public Limited Company, a British-American company providing insurance services, healthcare benefit costs increased from 8.2% in 2021 to 8.8% in 2022 and are expected to grow again in 2023 to a high global average of 10%. Therefore, the increased healthcare expenditure will drive the growth of the soft tissue sarcoma market.

Major companies operating in the soft tissue sarcoma market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck & Co. Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Lupin Ltd., Philogen S.p.A., Taiho Pharmaceutical Co.Ltd., Nanobiotix S.A.

Product Innovation Driving Advancements In Soft Tissue Sarcoma Market

Product innovation has emerged as a key trend gaining popularity in the soft tissue sarcoma market. Major companies operating in the soft tissue sarcoma market are concentrating on creating innovative products to strengthen their position in the market. For instance, in November 2023, Mercy, a US-based not-for-profit Catholic healthcare organization, introduced an innovative AI-driven texting program called The Chen Chemotherapy Model to proactively prevent hospitalizations related to chemotherapy. This program utilizes a smart texting platform that sends daily messages to chemotherapy patients seven days a week, excluding weekends and holidays. The texts present a list of symptoms, including diarrhea, pain, fever, fatigue, nausea or vomiting, or no symptoms. Patients can select and rate their symptoms, and based on their responses, the information may be escalated to their healthcare provider. The goal is to identify potential issues early and intervene before symptoms worsen, demonstrating Mercy's commitment to leveraging technology for improved patient care in the field of chemotherapy.

Research Initiatives Shaping The Soft Tissue Sarcoma Market Landscape

Major companies operating in the soft tissue sarcoma market are focusing on research projects such as the Leiomyosarcoma Project (LMS) to sustain their position in the market. Leiomyosarcoma Project (LMS) refers to a project that aims to advance scientific discovery and understanding of leiomyosarcoma, which is a rare and aggressive form of cancer that arises in smooth muscle cells, typically found in the walls of organs like the uterus, stomach, or intestines. For instance, in September 2022, Count Me In, a US-based non-profit cancer research initiative, launched the Leiomyosarcoma Project (LMS), inviting individuals with the rare cancer leiomyosarcoma to actively participate in research. This initiative aims to accelerate scientific discovery and enhance understanding of leiomyosarcoma by partnering with patients. Count Me In already runs the Osteosarcoma Project (OS), another rare cancer research effort, following a similar patient-partnered model. In these projects, patients are encouraged to share their health data, contributing to a collaborative and data-driven approach to advance research and improve outcomes for individuals with these rare cancers.

Ipsen Sa Acquires Epizyme Inc. For Soft Tissue Sarcoma Drug Portfolio

In August 2022, Ipsen SA, a France-based biopharmaceutical company, acquired Epizyme Inc. for an undisclosed amount. Through this acquisition, Ipsen SA accesses the Tazverik (tazemetostat) lead drug developed by Epizyme, a first-in-class, chemotherapy-free EZH2a inhibitor, and acquires EZM0414, a first-in-class, oral SETD2 inhibitor. Epizyme Inc. is a US-based biopharmaceutical company that develops drugs for treating soft tissue sarcoma.

North America was the largest region in the soft tissue sarcoma market in 2023. Asia-Pacific is expected to be the fastest-growing region in the soft tissue sarcoma market report during the forecast period. The regions covered in the soft tissue sarcoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the soft tissue sarcoma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The soft tissue sarcoma includes revenues earned by entities by immunotherapy, hormone therapy, photodynamic therapy, and stem cell transplant. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The soft tissue sarcoma market research report is one of a series of new reports from The Business Research Company that provides soft tissue sarcoma market statistics, including soft tissue sarcoma industry global market size, regional shares, competitors with a soft tissue sarcoma market share, detailed soft tissue sarcoma market segments, market trends and opportunities, and any further data you may need to thrive in the soft tissue sarcoma industry. This soft tissue sarcoma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Soft Tissue Sarcoma Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $3.13 billion
Revenue Forecast In 2033 $4.3 billion
Growth Rate CAGR of 8.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Treatment: Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, Other Treatments
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc.; Johnson & Johnson; Roche Holding AG; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi SA; Bristol Myers Squibb; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Merck & Co. Inc.; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Astellas Pharma Inc.; Daiichi Sankyo Company Limited; Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Ltd.; Lupin Ltd.; Philogen S.p.A.; Taiho Pharmaceutical Co.Ltd.; Nanobiotix S.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Soft Tissue Sarcoma Market Characteristics

    3. Soft Tissue Sarcoma Market Trends And Strategies

    4. Soft Tissue Sarcoma Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Soft Tissue Sarcoma Market Size and Growth

    5.1. Global Soft Tissue Sarcoma Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Soft Tissue Sarcoma Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Soft Tissue Sarcoma Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Soft Tissue Sarcoma Market Segmentation

    6.1. Global Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Targeted Therapy

    Chemotherapy

    Anti-Angiogenesis Drugs

    Radiation Therapy

    Other Treatments

    6.2. Global Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    Other Route of Administrations

    6.3. Global Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Homecare

    Specialty Centers

    Other End-Users

    7. Soft Tissue Sarcoma Market Regional And Country Analysis

    7.1. Global Soft Tissue Sarcoma Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Soft Tissue Sarcoma Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Soft Tissue Sarcoma Market

    8.1. Asia-Pacific Soft Tissue Sarcoma Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Soft Tissue Sarcoma Market

    9.1. China Soft Tissue Sarcoma Market Overview

    9.2. China Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Soft Tissue Sarcoma Market

    10.1. India Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Soft Tissue Sarcoma Market

    11.1. Japan Soft Tissue Sarcoma Market Overview

    11.2. Japan Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Soft Tissue Sarcoma Market

    12.1. Australia Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Soft Tissue Sarcoma Market

    13.1. Indonesia Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Soft Tissue Sarcoma Market

    14.1. South Korea Soft Tissue Sarcoma Market Overview

    14.2. South Korea Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Soft Tissue Sarcoma Market

    15.1. Western Europe Soft Tissue Sarcoma Market Overview

    15.2. Western Europe Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Soft Tissue Sarcoma Market

    16.1. UK Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Soft Tissue Sarcoma Market

    17.1. Germany Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Soft Tissue Sarcoma Market

    18.5. France Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Soft Tissue Sarcoma Market

    19.9. Italy Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Soft Tissue Sarcoma Market

    20.13. Spain Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Soft Tissue Sarcoma Market

    21.1. Eastern Europe Soft Tissue Sarcoma Market Overview

    21.2. Eastern Europe Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Soft Tissue Sarcoma Market

    22.1. Russia Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Soft Tissue Sarcoma Market

    23.1. North America Soft Tissue Sarcoma Market Overview

    23.2. North America Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Soft Tissue Sarcoma Market

    24.1. USA Soft Tissue Sarcoma Market Overview

    24.2. USA Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Soft Tissue Sarcoma Market

    25.1. Canada Soft Tissue Sarcoma Market Overview

    25.2. Canada Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Soft Tissue Sarcoma Market

    26.1. South America Soft Tissue Sarcoma Market Overview

    26.2. South America Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Soft Tissue Sarcoma Market

    27.1. Brazil Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Soft Tissue Sarcoma Market

    28.1. Middle East Soft Tissue Sarcoma Market Overview

    28.2. Middle East Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Soft Tissue Sarcoma Market

    29.1. Africa Soft Tissue Sarcoma Market Overview

    29.2. Africa Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Soft Tissue Sarcoma Market Competitive Landscape And Company Profiles

    30.1. Soft Tissue Sarcoma Market Competitive Landscape

    30.2. Soft Tissue Sarcoma Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Roche Holding AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. F. Hoffmann-La Roche Ltd.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AbbVie Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Soft Tissue Sarcoma Market Other Major And Innovative Companies

    31.1. Bayer AG

    31.2. Novartis AG

    31.3. Sanofi SA

    31.4. Bristol Myers Squibb

    31.5. AstraZeneca plc

    31.6. GlaxoSmithKline plc

    31.7. Takeda Pharmaceutical Company Limited

    31.8. Eli Lilly and Company

    31.9. Merck & Co. Inc.

    31.10. Amgen Inc.

    31.11. Teva Pharmaceutical Industries Ltd.

    31.12. Mylan N.V.

    31.13. Astellas Pharma Inc.

    31.14. Daiichi Sankyo Company Limited

    31.15. Sun Pharmaceutical Industries Ltd.

    32. Global Soft Tissue Sarcoma Market Competitive Benchmarking

    33. Global Soft Tissue Sarcoma Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Soft Tissue Sarcoma Market

    35. Soft Tissue Sarcoma Market Future Outlook and Potential Analysis

    35.1 Soft Tissue Sarcoma Market In 2028 - Countries Offering Most New Opportunities

    35.2 Soft Tissue Sarcoma Market In 2028 - Segments Offering Most New Opportunities

    35.3 Soft Tissue Sarcoma Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Soft Tissue Sarcoma Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Soft Tissue Sarcoma Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Johnson & Johnson Financial Performance
  • Table 76: Roche Holding AG Financial Performance
  • Table 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 78: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Soft Tissue Sarcoma Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Soft Tissue Sarcoma Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Soft Tissue Sarcoma Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Soft Tissue Sarcoma Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Soft Tissue Sarcoma Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Johnson & Johnson Financial Performance
  • Figure 76: Roche Holding AG Financial Performance
  • Figure 77: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 78: AbbVie Inc. Financial Performance
Opportunities And Strategies Analysis For The General Lighting Market – Includes General Lighting Market Segments
Read More
Forecasting till 2030: Opportunities And Strategies In The Global Helium Market – Includes Global Helium Market Trends
Read More
Forecasting Till 2030: Opportunities And Strategies In The Global Smart Lighting Market – Includes Smart Lighting Market Share
Read More
Global Electrical Equipment Market Opportunities And Strategies – Forecast To 2030 – Includes Electrical Equipment Market Overview
Read More
The Business Research Company offers the allium nitride semiconductor devices market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the unified communication and business headsets market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the automotive wiring harness market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the ithium sulfur batteries market research report 2022 with industry size, share, segments and market growth
Read More
Gene Editing Global Market Report 2024 – By Technology (CRISPR, TALEN, ZFN), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmaceutical, Contract Research Organization) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Gene Therapy Global Market Report 2024 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders), By End Users (Biopharmaceutical Companies, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Stem Cell Global Market Report 2024 – By Source (Autologous, Allogeneic), By Product Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Other Products), By Application (Regenerative Medicine, Drug Discovery And Development) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Stem Cell/Cord Blood Banking Global Market Report 2024 – By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type (Public, Private), By Application (Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Stem Cell Therapy Global Market Report 2024 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others), By End-Users (Hospitals And Clinics, Research Centers, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Molecular Diagnostics Devices And Equipment Global Market Report 2024 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell and Gene Therapy Global Market Report 2024 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Based Assays Global Market Report 2024 – By Product & Service (Consumables, Instruments, Services, Software), By Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies), By Application (Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the soft tissue sarcoma market?

Soft tissue sarcoma refers to a disease where cancer cells form in the soft tissues of the body which can be diagnosed through biopsy techniques. It is commonly caused in tissues including blood arteries, muscle, neurons, and fat. For further insights on the soft tissue sarcoma market, request a sample here

How will the soft tissue sarcoma market drivers and restraints affect the soft tissue sarcoma market dynamics? What forces will shape the soft tissue sarcoma industry going forward?

The soft tissue sarcoma market major growth driver - Surge In Cancer Incidence Driving Soft Tissue Sarcoma Market Growth. For further insights on the soft tissue sarcoma market, request a sample here

What is the forecast market size or the forecast market value of the soft tissue sarcoma market?

The soft tissue sarcoma market size has grown strongly in recent years. It will grow from $2.87 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to limited treatment options, evolving understanding of sarcoma biology, growth in cancer research funding, rising prevalence of soft tissue sarcoma, expansion of healthcare infrastructure. The soft tissue sarcoma market size is expected to see strong growth in the next few years. It will grow to $4.3 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to development of targeted therapies for soft tissue sarcoma, increasing focus on personalized medicine, expansion of clinical trials for sarcoma treatments, growing awareness and early detection initiatives,. Major trends in the forecast period include integration of immunotherapy in soft tissue sarcoma treatment, development of combination therapies, emphasis on patient-centric care models, rise in the use of liquid biopsies, advances in sarcoma genomics. For further insights on the soft tissue sarcoma market, request a sample here

How is the soft tissue sarcoma market segmented?

The soft tissue sarcoma market is segmented
1) By Treatment: Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, Other Treatments
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-UsersFor further insights on the soft tissue sarcoma market, request a sample here

Which region has the largest share of the soft tissue sarcoma market? What are the other regions covered in the report?

North America was the largest region in the soft tissue sarcoma market in 2023. Asia-Pacific is expected to be the fastest-growing region in the soft tissue sarcoma market report during the forecast period. The regions covered in the soft tissue sarcoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the soft tissue sarcoma market, request a sample here.

Who are the major players in the soft tissue sarcoma market?

Major companies operating in the soft tissue sarcoma market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck & Co. Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Lupin Ltd., Philogen S.p.A., Taiho Pharmaceutical Co.Ltd., Nanobiotix S.A. For further insights on the soft tissue sarcoma market, request a sample here.

What are the key trends in the soft tissue sarcoma market?

Major trend in the soft tissue sarcoma market - Product Innovation Driving Advancements In Soft Tissue Sarcoma Market. For further insights on the soft tissue sarcoma market, request a sample here.

What are the major opportunities in the soft tissue sarcoma market? What are the strategies for the soft tissue sarcoma market?

For detailed insights on the major opportunities and strategies in the soft tissue sarcoma market, request a sample here.

How does the soft tissue sarcoma market relate to the overall economy and other similar markets?

For detailed insights on soft tissue sarcoma market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the soft tissue sarcoma industry?

For detailed insights on the mergers and acquisitions in the soft tissue sarcoma industry, request a sample here.

What are the key dynamics influencing the soft tissue sarcoma market growth? SWOT analysis of the soft tissue sarcoma market.

For detailed insights on the key dynamics influencing the soft tissue sarcoma market growth and SWOT analysis of the soft tissue sarcoma industry, request a sample here.